Paper10073740
The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
Gisleskog PO and 3 others. Br J Clin Pharmacol, 1999. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. Papers, record 10073740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azasteroids | Major topic |
| Enzyme Inhibitors | Major topic |
| Oxidoreductases | Major topic |
| Adult | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Dutasteride | |
| Half-Life | |
| Humans | |
| Male | |
| Middle Aged | |
| Models, Biological | |
| Placebos | |
| Single-Blind Method |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1714529 | High prevalence of benign prostatic hypertrophy in the community. | Lancet | 1991 | https://conductscience.org/library/papers/1714529 | PubMed |
| 2 | 1383817 | Is the prostate pill finally here? | N Engl J Med | 1992 | https://conductscience.org/library/papers/1383817 | PubMed |
| 3 | 7979239 | Steroid 5 alpha-reductase: two genes/two enzymes. | Annu Rev Biochem | 1994 | https://conductscience.org/library/papers/7979239 | PubMed |
| 4 | 9871428 | A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride. | Clin Pharmacol Ther | 1998 | https://conductscience.org/library/papers/9871428 | PubMed |
| 5 | 8575497 | Proscar: five-year experience. | Eur Urol | 1995 | https://conductscience.org/library/papers/8575497 | PubMed |
| 6 | 9316864 | Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. | J Pharmacol Exp Ther | 1997 | https://conductscience.org/library/papers/9316864 | PubMed |
| 7 | 7577933 | Mechanism of time-dependent inhibition of 5 alpha-reductases by delta 1-4-azasteroids: toward perfection of rates of time-dependent inhibition by using ligand-binding energies. | Biochemistry | 1995 | https://conductscience.org/library/papers/7577933 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41501168 | SRD5A2 and emerging therapies in androgen-driven disorders. | Nat Rev Urol | 2026 | https://conductscience.org/library/papers/41501168 | PubMed |
| 41366580 | Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics. | AAPS J | 2025 | https://conductscience.org/library/papers/41366580 | PubMed |
| 39641480 | Topical dutasteride for androgenic alopecia: current state and prospects. | Ther Deliv | 2025 | https://conductscience.org/library/papers/39641480 | PubMed |
| 37554681 | Combination and Rotational Therapy in Androgenetic Alopecia. | J Cutan Aesthet Surg | 2023 | https://conductscience.org/library/papers/37554681 | PubMed |
| 30588787 | Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment. | World J Mens Health | 2019 | https://conductscience.org/library/papers/30588787 | PubMed |
| 29907425 | Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats. | Neuropharmacology | 2019 | https://conductscience.org/library/papers/29907425 | PubMed |
| 25281165 | Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry. | Talanta | 2015 | https://conductscience.org/library/papers/25281165 | PubMed |
| 24823464 | 5α-reductase type 1 modulates insulin sensitivity in men. | J Clin Endocrinol Metab | 2014 | https://conductscience.org/library/papers/24823464 | PubMed |
| 24615171 | Pharmacokinetic bioequivalence studies of a fixed-dose combination of tamsulosin and dutasteride in healthy volunteers. | Clin Drug Investig | 2014 | https://conductscience.org/library/papers/24615171 | PubMed |
| 24557088 | Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment. | Psychopharmacology (Berl) | 2014 | https://conductscience.org/library/papers/24557088 | PubMed |
| 23737668 | Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/23737668 | PubMed |
| 22970204 | A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance. | PLoS One | 2012 | https://conductscience.org/library/papers/22970204 | PubMed |
| 22044402 | Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. | Br J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22044402 | PubMed |
| 16783479 | Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B4 synthesis inhibitor. | Pharm Res | 2006 | https://conductscience.org/library/papers/16783479 | PubMed |
| 14565784 | Dutasteride. | Drugs Aging | 2003 | https://conductscience.org/library/papers/14565784 | PubMed |
| 12934061 | Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. | Int J Impot Res | 2003 | https://conductscience.org/library/papers/12934061 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10073740
GET https://conductscience.org/api/papers/v1/10073740/authors